Pharmacy vs. medical benefit: how prior authorization differs
A specialty pharmacy may supply a drug covered under the medical benefit. The plan's rules determine the authorization route, the reviewer, and who bills for the drug.
The benefit covering a specialty drug does not, by itself, identify who supplies it or reviews its authorization. A pharmacy may supply a drug billed under the medical benefit; a clinic may administer a drug paid through the pharmacy benefit.
Keep benefit and supply separate
| Question | Pharmacy benefit | Medical benefit |
|---|---|---|
| Who usually reviews? | PBM or pharmacy-benefit administrator | Plan or delegated utilization-management organization |
| What identifies the request? | Drug, NDC, quantity, days supply | Drug or service, HCPCS/CPT, dose, units, setting |
| Who may bill the drug? | Dispensing pharmacy | Clinic or contracted specialty pharmacy, depending on arrangement |
| What else must be checked? | Formulary, required pharmacy, quantity limits | Medical policy, supplier restrictions, site of care |
UnitedHealthcare's medication-sourcing guidance provides a concrete example: a designated specialty pharmacy can ship a drug to the clinic and bill it under the member's medical benefit. UHC sourcing protocol. Pharmacy supply alone therefore does not identify the benefit.
TMS is a procedure rather than a dispensed drug; identify its medical or behavioral-health administrator. Spravato can involve a separate drug-supply arrangement alongside clinic services. For either, the insurer's logo is insufficient when a delegated organization manages the benefit.
Resolve the route for the actual member
- 01Identify the planUse the member's product, state, network, and effective dates.
- 02Check benefit evidenceRead eligibility details and current pharmacy and medical policies.
- 03Confirm supply and reviewerIdentify the permitted supplier, authorization recipient, and service setting.
- 04Resolve uncertaintyAssign a benefits investigation when sources conflict or omit the answer.
An eligibility inquiry can request service type 88 for pharmacy, but supported service types and response detail vary by payer. Stedi's payer-specific service-type reference documents that variation. An active response does not by itself establish the route for a particular drug.
Check both the formulary and the medical-drug policy. If the product appears in both, confirm which arrangement applies to this member. A policy for one commercial product may not govern the insurer's Medicaid or Medicare Advantage members.
Diagnose the message before appealing it
A wrong-route request may be rejected, returned for redirection, or denied. A generic noncovered message is a reason to investigate; it does not prove that the benefit was wrong. Read the full response and confirm what the receiving organization actually reviewed.
| Finding | Next action |
|---|---|
| Wrong benefit administrator | Confirm the correct recipient and its submission requirements |
| Required specialty pharmacy was bypassed | Resolve the acquisition arrangement before buying another dose |
| Site of care is outside policy | Review the approved setting or the plan's exception process |
| The policy changed mid-course | Check effective dates and any transition terms |
How Foresight helps
Foresight records the benefit type on each authorization and separates pharmacy and medical work in the queue. Its routing records retain the payer, product identifiers, state and plan details, source, verification date, and confidence. Staff can inspect the basis for an answer instead of relying on a remembered rule.
In the medical-authorization workflow, an unresolved route becomes a review task. A request identified as pharmacy work is held for the appropriate handoff. The hold carries the routing evidence, so the next coordinator can continue the investigation without starting over.
See how this applies to PrEP drug and service billing and other specialty workflows.
01Does clinic administration always mean medical benefit?
No. The benefit and acquisition arrangement depend on the plan and product. Confirm both before authorizing or billing the drug.
02Can an eligibility response replace the policy check?
No. It can establish useful benefit facts, but drug-specific authorization, supply, and site requirements may need policy review or confirmation with the administrator.